Thriving from a recessionary footing means seizing opportunities from a sector’s bearish cycle READ TIME - 7 MIN. Our outlook for Healthcare and the Life Sciences is as bullish as ever. But recent trends might lead some to feel otherwise. For the sector that has long...
The 2022 Report- Board & Executive Compensation in the Biotech Industry
Bedford Group Transearch Life Sciences today announced their annual publication of The 2022 Executive & Board Compensation Report in the Biotechnology industry. This report details findings from an analysis of compensation composition and earnings for Named...
The Bedford Report 2022- Chief Financial Officer Compensation in the Medtech Industry
The NEW 2022 Bedford Group Transearch Report on Chief Financial Officer Compensation in the Medtech Industry is now available for download. This report is an industry-wide survey of compensation awards and practices for CFOs in the sector, focusing on micro, small and...
The Bedford Report 2022- Board of Directors Compensation in the Medtech Industry
The NEW 2022 Bedford Group Transearch Report on Board of Directors Compensation in the Medtech Industry is now available for download. This report is Bedford’s first annual industry-wide survey of compensation awards and practices in the sector, focusing on micro,...
The Bedford Report 2022- Chief Executive Officer Compensation in the Medtech Industry.
The NEW 2022 Bedford Group Transearch Report on CEO Compensation in the Medtech Industry is now available for download. This report is Bedford's first annual industry-wide survey of compensation awards and practices in the sector, focusing on micro, small and mid-cap...
The Bedford Report 2021- Board & Executive Compensation in the Cannabis Industry.
The 2021 Bedford Group Transearch Report on Board and Executive Compensation in the Cannabis Industry is now available for download. This is an industry-wide survey of compensation awards and practices for C-level executives and board members, and provides insights...
The Healthcare Transformational Leadership Series
In an interview with The Bedford Group TRANSEARCH, Zahid Salman, President & CEO of Green Shield Canada (GSC), discusses transformation leadership in the health benefits industry. Discover how Zahid is transforming GSC and the key challenges faced along this...
Global Life Sciences Executive Joins Bedford Group Transearch’s Healthcare Advisory Board
TORONTO and CAMBRIDGE, Mass., Jan. 18, 2022 /CNW/ - Bedford Group Transearch Life Sciences is proud to announce Rehan Verjee has joined their North American Healthcare Advisory Board. "During a unique business environment in 2021,...
FAST FORWARD REWIND
Putting an unprecedented year in the rear view and what it says about the one to come Last December, we wrote that 2020 would be a hard year to forget. Ten months of pandemic life had clouded our sense of clarity and purpose — no 20/20 in 2020. As we headed into our...
ASCENSION DEFICIT- The Challenge of Finding Leaders for the Life Sciences
Wherever you look, demand is high, supply is constrained. Nowhere is this more true than in the hyper-competitive arena of executive and board search. And in no other sector has competition reached a higher pitch than in Healthcare and the Life Sciences. Howard Pezim...
Bedford Newsletter: Can Biotech Be A Diversity Leader?
CAN BIOTECH BE A DIVERSITY LEADER? Biotech Compensation Report tells the story of a thriving sector that still has room to grow. It's been a big year for biotech. And that momentum shows little sign of abating. Market predictions have sector growth topping nearly 16%...
Bedford Group/TRANSEARCH Publishes First Annual 2021 Executive Compensation Report Covering the Biotechnology Industry
Bedford Group/TRANSEARCH Publishes First Annual 2021 Executive Compensation Report Covering the Biotechnology Industry Report underscores salary inequities across race and gendersJune 29, 2021 07:00 AM Eastern Daylight Time CAMBRIDGE, Mass. & TORONTO--(BUSINESS...